Pay in 4 interest-free payments of $5.82 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
It does this by interacting with the part of the brain that controls hunger and overall food intake
This treatment works best for small to moderate fat deposits rather than significant body contouring projects
The only shelf life that should be followed is the one stated on the IMP label or clinical trial protocol provided by the trial sponsor
It does not offer nutrition guidance, fitness support, or any behavioral program alongside treatment
The average baseline characteristics in the trial included 71 % women, 42 % of hypertensive patients, 19 % with type 2 diabetes mellitus, 28 % with a body mass index greater than 40 kg/m2 corresponding to obesity, and 4 % with cardiovascular conditions
Patience and consistency are vital when working with cellular-level support
